These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 17952078)

  • 21. Roles of the NKG2D immunoreceptor and its ligands.
    Raulet DH
    Nat Rev Immunol; 2003 Oct; 3(10):781-90. PubMed ID: 14523385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-12 improves cytotoxicity of natural killer cells via upregulated expression of NKG2D.
    Zhang C; Zhang J; Niu J; Zhou Z; Zhang J; Tian Z
    Hum Immunol; 2008 Aug; 69(8):490-500. PubMed ID: 18619507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The activating NKG2D receptor assembles in the membrane with two signaling dimers into a hexameric structure.
    Garrity D; Call ME; Feng J; Wucherpfennig KW
    Proc Natl Acad Sci U S A; 2005 May; 102(21):7641-6. PubMed ID: 15894612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways.
    Verhoeven DH; de Hooge AS; Mooiman EC; Santos SJ; ten Dam MM; Gelderblom H; Melief CJ; Hogendoorn PC; Egeler RM; van Tol MJ; Schilham MW; Lankester AC
    Mol Immunol; 2008 Sep; 45(15):3917-25. PubMed ID: 18657862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct receptor repertoire formation in mouse NK cell subsets regulated by MHC class I expression.
    Hayakawa Y; Watt SV; Takeda K; Smyth MJ
    J Leukoc Biol; 2008 Jan; 83(1):106-11. PubMed ID: 17940219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NKG2D.
    Lanier LL
    J Biol Regul Homeost Agents; 2003; 17(4):338-40. PubMed ID: 15065764
    [No Abstract]   [Full Text] [Related]  

  • 27. Insights into seven and single transmembrane-spanning domain receptors and their signaling pathways in human natural killer cells.
    Maghazachi AA
    Pharmacol Rev; 2005 Sep; 57(3):339-57. PubMed ID: 16109839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of NKG2D receptor function by antibody therapy attenuates transfer-induced colitis in SCID mice.
    Kjellev S; Haase C; Lundsgaard D; Ursø B; Tornehave D; Markholst H
    Eur J Immunol; 2007 May; 37(5):1397-406. PubMed ID: 17407193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Up-regulation of NKG2D ligands by AML cells to increase sensitivity to NK cells: the tumour might strike back. Comment on "differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis" by Rohner et al. [Leuk Res 2007;31:1393-402].
    Zimmer J; Michel T; Andrès E; Hentges F
    Leuk Res; 2008 Apr; 32(4):676-7. PubMed ID: 17920678
    [No Abstract]   [Full Text] [Related]  

  • 30. An activating immunoreceptor complex formed by NKG2D and DAP10.
    Wu J; Song Y; Bakker AB; Bauer S; Spies T; Lanier LL; Phillips JH
    Science; 1999 Jul; 285(5428):730-2. PubMed ID: 10426994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How NKG2D ligands trigger autoimmunity?
    Caillat-Zucman S
    Hum Immunol; 2006 Mar; 67(3):204-7. PubMed ID: 16698443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IFN-gamma production and degranulation are differentially regulated in response to stimulation in murine natural killer cells.
    Vahlne G; Becker S; Brodin P; Johansson MH
    Scand J Immunol; 2008 Jan; 67(1):1-11. PubMed ID: 18028287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-15 improves cytotoxicity of natural killer cells via up-regulating NKG2D and cytotoxic effector molecule expression as well as STAT1 and ERK1/2 phosphorylation.
    Zhang C; Zhang J; Niu J; Zhang J; Tian Z
    Cytokine; 2008 Apr; 42(1):128-36. PubMed ID: 18280748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NKG2D splice variants: a reexamination of adaptor molecule associations.
    Rabinovich B; Li J; Wolfson M; Lawrence W; Beers C; Chalupny J; Hurren R; Greenfield B; Miller R; Cosman D
    Immunogenetics; 2006 Apr; 58(2-3):81-8. PubMed ID: 16470377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway.
    Ito A; Shimura H; Nitahara A; Tomiyama K; Ito M; Kanekura T; Okumura K; Yagita H; Kawai K
    Int Immunol; 2008 Oct; 20(10):1343-9. PubMed ID: 18697765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vav1 controls DAP10-mediated natural cytotoxicity by regulating actin and microtubule dynamics.
    Graham DB; Cella M; Giurisato E; Fujikawa K; Miletic AV; Kloeppel T; Brim K; Takai T; Shaw AS; Colonna M; Swat W
    J Immunol; 2006 Aug; 177(4):2349-55. PubMed ID: 16887996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer immunosurveillance: NKG2D breaks cover.
    Ljunggren HG
    Immunity; 2008 Apr; 28(4):492-4. PubMed ID: 18400193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential NKG2D binding to highly related human NKG2D ligands ULBP2 and RAET1G is determined by a single amino acid in the alpha2 domain.
    Wittenbrink M; Spreu J; Steinle A
    Eur J Immunol; 2009 Jun; 39(6):1642-51. PubMed ID: 19424970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased risk of colorectal cancer with the high natural killer cell activity NKG2D genotype in Japanese.
    Furue H; Matsuo K; Kumimoto H; Hiraki A; Suzuki T; Yatabe Y; Komori K; Kanemitsu Y; Hirai T; Kato T; Ueda M; Ishizaki K; Tajima K
    Carcinogenesis; 2008 Feb; 29(2):316-20. PubMed ID: 18174257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potentiation of NK cell-mediated cytotoxicity in human lung adenocarcinoma: role of NKG2D-dependent pathway.
    Le Maux Chansac B; Missé D; Richon C; Vergnon I; Kubin M; Soria JC; Moretta A; Chouaib S; Mami-Chouaib F
    Int Immunol; 2008 Jul; 20(7):801-10. PubMed ID: 18441340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.